MicroRNA-384 Inhibits the Progression of Papillary Thyroid Cancer by Targeting PRKACB
Background. Growing evidence shows that dysregulation of miRNAs plays a significant role in papillary thyroid cancer (PTC) tumorigenesis and development. The abnormal expression of miR-384 has been acknowledged in the proliferation or metastasis of some cancers. However, the function and the underly...
Main Authors: | Yongxia Wang, Beixi Wang, Hong Zhou, Xiangnan Zhang, Xinlai Qian, Jing Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2020/4983420 |
Similar Items
-
MicroRNA-384 inhibits proliferation migration and invasion of glioma by targeting at CDC42
by: Gu G, et al.
Published: (2018-07-01) -
MicroRNA-200a-3p Mediates Neuroprotection in Alzheimer-Related Deficits and Attenuates Amyloid-Beta Overproduction and Tau Hyperphosphorylation via Coregulating BACE1 and PRKACB
by: Linlin Wang, et al.
Published: (2019-07-01) -
Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma
by: Azliana Mohamad Yusof, et al.
Published: (2018-04-01) -
Regulatory role of PTEN and microRNA-141 in papillary thyroid cancer
by: Xianfeng Zhong, et al.
Published: (2020-01-01) -
MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1
by: Hai-Xiang Yu, et al.
Published: (2019-01-01)